3-150409667-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001303264.2(TSC22D2):c.317G>T(p.Gly106Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,598,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001303264.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSC22D2 | NM_001303264.2 | c.317G>T | p.Gly106Val | missense_variant | 1/3 | ENST00000688009.1 | NP_001290193.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSC22D2 | ENST00000688009.1 | c.317G>T | p.Gly106Val | missense_variant | 1/3 | NM_001303264.2 | ENSP00000510392 | A2 | ||
TSC22D2 | ENST00000361875.8 | c.317G>T | p.Gly106Val | missense_variant | 1/4 | 1 | ENSP00000354543 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000107 AC: 23AN: 214218Hom.: 0 AF XY: 0.0000508 AC XY: 6AN XY: 118198
GnomAD4 exome AF: 0.0000595 AC: 86AN: 1446228Hom.: 0 Cov.: 30 AF XY: 0.0000487 AC XY: 35AN XY: 717986
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | The c.317G>T (p.G106V) alteration is located in exon 1 (coding exon 1) of the TSC22D2 gene. This alteration results from a G to T substitution at nucleotide position 317, causing the glycine (G) at amino acid position 106 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at